Trouvez les meilleures technologies du CNRS pour mener à bien votre projet d’innovation.
06.11.2018
Matériaux – Revêtements 07293-01
06.11.2018
Matériaux – Revêtements 10581-01
06.11.2018
Chimie 08758-01
06.11.2018
11127-01
06.11.2018
Environnement et Energie 11107-01
19.10.2018
Diagnostic médical 08504-01
Nous pouvons vous accompagner sur toute votre
démarche de transfert de technologies.
Grâce à notre expérience, nos réseaux et notre connaissance de l’écosystème de l’innovation nous vous accompagnons tout au long de votre projet.
00017-04
European priority patent application n°EP11306082.6 filed on August 30, 2011 and entitled “Protein complex, inhibitors thereof, and their use as drugs”
Marcel MECHALI
Malik LUTZMANN
Bernard DE MASSY
Corinne GREY
Sabine TRAVER
Exclusive or non-exclusive licenses, Collaborative agreement
Institut de Génétique Humaine (IGH, UPR1142) in Montpellier, France
The MiniChromosome Maintenance family (MCM2-9) comprises structurally related proteins required to initiate DNA synthesis in eukaryotes. These proteins function in a complex very likely as a DNA helicase in promoting the opening of the DNA double helix at replication origins.
MCM8 and MCM9 are the last discovered members of the eight MCM family proteins. The functions of MCM8 and MCM9, which are present in all vertebrates but absent in yeast, C. elegans, and some other eukaryotic taxa, are far less documented.
A mechanism essential to preserve genome integrity during both mitotic cell division and the formation of germ cells at meiosis is the repair of double strand DNA breaks (DSBs) by homologous recombination (HR).
The inventors have observed that lack of MCM8/MCM9 complex induces animal sterility. They have shown that deficiency for these genes impairs homologous recombination (HR)-mediated DNA repair during gametogenesis and somatic cells cycles.
This invention concerns a composition comprising either an isolated protein complex comprising MCM8 and MCM9 proteins, or nucleic acid molecules coding for the proteins that constitute said complex, or compounds inhibiting the formation and/or the stability, or the activity of said complex, for its use for enhancing or reducing animal fertility.
This innovation could be used for controlling fertility or sterility:
31.03.2015
Santé / Thérapeutique, Diagnostic médical 06081-01
03.03.2014
Santé / Thérapeutique 03946-01
26.02.2014
Santé / Thérapeutique 02884-01
06.11.2018
Matériaux – Revêtements 07293-01
06.11.2018
Matériaux – Revêtements 10581-01
06.11.2018
Chimie 08758-01
06.11.2018
11127-01
06.11.2018
Environnement et Energie 11107-01
19.10.2018
Diagnostic médical 08504-01